Kang Mun Su, Park Dong Il, Oh Se Yong, Yoo Tae Woo, Ryu Seung Ho, Park Jung Ho, Kim Hong Joo, Cho Yong Kyun, Sohn Chong Il, Jeon Woo Kyu, Kim Byung Ik
Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
J Gastroenterol Hepatol. 2007 Oct;22(10):1656-61. doi: 10.1111/j.1440-1746.2006.04518.x.
The relationship between obesity and gastroesophageal reflux disease (GERD) is controversial. The aim of the present study was to investigate the potential roles of body mass index (BMI) and waist circumference on GERD in a Korean population.
A total of 2457 subjects who visited the Kangbuk Samsung Hospital medical screening center for esophagogastroduodenoscopy from September 2004 to April 2005 were enrolled. All participants were given a questionnaire to determine reflux symptoms. Abdominal obesity was defined as a waist circumference > or =80 cm in women and > or =90 cm in men.
The proportion of subjects in each BMI group was 68.9%, 28.7% and 2.4% for BMI <25, 25-30 and >30, respectively. The prevalence of abdominal obesity was 24.2%. The prevalence of reflux symptoms was 8.2%. Neither BMI nor abdominal obesity was significantly associated with reflux symptoms after adjustment. The prevalence of erosive esophagitis was 6.6%. There was a clear dose-response relationship between prevalence of erosive esophagitis and BMI (5.6%, 8.1% and 15.5% for BMI <25, 25-30 and >30, respectively, P = 0.002). Abdominal obesity was also associated with erosive esophagitis (odds ratio, 2.3; 95% confidence interval, 1.6-3.1). However, only the association between abdominal obesity and erosive esophagitis remained strong after adjustments.
Abdominal obesity rather than BMI is an independent risk factor for erosive esophagitis in the Korean population.
肥胖与胃食管反流病(GERD)之间的关系存在争议。本研究的目的是调查韩国人群中体重指数(BMI)和腰围对GERD的潜在作用。
纳入2004年9月至2005年4月期间到江北三星医院医疗筛查中心接受食管胃十二指肠镜检查的2457名受试者。所有参与者都填写了一份问卷以确定反流症状。腹部肥胖定义为女性腰围≥80厘米,男性腰围≥90厘米。
BMI<25、25-30和>30的各BMI组受试者比例分别为68.9%、28.7%和2.4%。腹部肥胖患病率为24.2%。反流症状患病率为8.2%。调整后,BMI和腹部肥胖均与反流症状无显著相关性。糜烂性食管炎患病率为6.6%。糜烂性食管炎患病率与BMI之间存在明显的剂量反应关系(BMI<25、25-30和>30时分别为5.6%、8.1%和15.5%,P=0.002)。腹部肥胖也与糜烂性食管炎相关(比值比,2.3;95%置信区间,1.6-3.1)。然而,调整后只有腹部肥胖与糜烂性食管炎之间的关联仍然很强。
在韩国人群中,腹部肥胖而非BMI是糜烂性食管炎独立的危险因素。